# Autolus Therapeutics (AUTL) — Overview

AUTL · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/autl

## Price

Last close $1.72 on Oct 15, 2026. 52-week range $1.21 – $2.54.

## Company profile

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $117.4M |
| Revenue (quarter) | $45.7M |
| Revenue growth (year over year) | 118.37% |
| Gross profit (trailing twelve months) | $18.4M |
| Gross margin | 15.66% |
| Net income (trailing twelve months) | −$280.2M |
| Net income (quarter) | −$39.1M |
| Net income growth (year over year) | 18.38% |
| Net margin | -238.65% |
| Return on equity | -133.00% |
| EPS (trailing twelve months) | −$1.06 |
| Book value per share | $0.28 |
| P/E (trailing twelve months) | — |
| Price to book | 6.1 |
| Debt to assets | 84.83% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Autolus Therapeutics (AUTL) profitable?

No. Autolus Therapeutics reported a net loss of $280.2M over the trailing twelve months.

### How much revenue does Autolus Therapeutics (AUTL) make?

Autolus Therapeutics generated $117.4M in revenue over the trailing twelve months, up 118.37% year over year.

### How do I buy stock in Autolus Therapeutics (AUTL)?

AUTL trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).